329 related articles for article (PubMed ID: 23295793)
1. Prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
Taneja SS; Morton R; Barnette G; Sieber P; Hancock ML; Steiner M
J Clin Oncol; 2013 Feb; 31(5):523-9. PubMed ID: 23295793
[TBL] [Abstract][Full Text] [Related]
2. Toremifene for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia: results of a double-blind, placebo controlled, phase IIB clinical trial.
Price D; Stein B; Sieber P; Tutrone R; Bailen J; Goluboff E; Burzon D; Bostwick D; Steiner M
J Urol; 2006 Sep; 176(3):965-70; discussion 970-1. PubMed ID: 16890670
[TBL] [Abstract][Full Text] [Related]
3. Re: prostate cancer diagnosis among men with isolated high-grade intraepithelial neoplasia enrolled onto a 3-year prospective phase III clinical trial of oral toremifene.
Taneja SS
J Urol; 2013 Aug; 190(2):536. PubMed ID: 23845334
[No Abstract] [Full Text] [Related]
4. Dutasteride for the prevention of prostate cancer in men with high-grade prostatic intraepithelial neoplasia: results of a phase III randomized open-label 3-year trial.
Milonas D; Auskalnis S; Skulcius G; Gudinaviciene I; Jievaltas M; Joniau S
World J Urol; 2017 May; 35(5):721-728. PubMed ID: 27644229
[TBL] [Abstract][Full Text] [Related]
5. TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia.
Park K; Dalton JT; Narayanan R; Barbieri CE; Hancock ML; Bostwick DG; Steiner MS; Rubin MA
J Clin Oncol; 2014 Jan; 32(3):206-11. PubMed ID: 24297949
[TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind placebo controlled phase I-II study on clinical and molecular effects of dietary supplements in men with precancerous prostatic lesions. Chemoprevention or "chemopromotion"?
Gontero P; Marra G; Soria F; Oderda M; Zitella A; Baratta F; Chiorino G; Gregnanin I; Daniele L; Cattel L; Frea B; Brusa P
Prostate; 2015 Aug; 75(11):1177-86. PubMed ID: 25893930
[TBL] [Abstract][Full Text] [Related]
7. Phase IIA clinical trial to test the efficacy and safety of Toremifene in men with high-grade prostatic intraepithelial neoplasia.
Steiner MS; Pound CR
Clin Prostate Cancer; 2003 Jun; 2(1):24-31. PubMed ID: 15046680
[TBL] [Abstract][Full Text] [Related]
8. Low testosterone level predicts prostate cancer in re-biopsy in patients with high grade prostatic intraepithelial neoplasia.
García-Cruz E; Piqueras M; Ribal MJ; Huguet J; Serapiao R; Peri L; Izquierdo L; Alcaraz A
BJU Int; 2012 Sep; 110(6 Pt B):E199-202. PubMed ID: 22257176
[TBL] [Abstract][Full Text] [Related]
9. Effect of nutritional supplement challenge in patients with isolated high-grade prostatic intraepithelial neoplasia.
Joniau S; Goeman L; Roskams T; Lerut E; Oyen R; Van Poppel H
Urology; 2007 Jun; 69(6):1102-6. PubMed ID: 17572195
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer and prostatic intraepithelial neoplasia: true, true, and unrelated?
Thompson IM; Leach R
J Clin Oncol; 2013 Feb; 31(5):515-6. PubMed ID: 23295801
[No Abstract] [Full Text] [Related]
11. Is low-grade prostatic intraepithelial neoplasia a risk factor for cancer?
Goeman L; Joniau S; Ponette D; Van der Aa F; Roskams T; Oyen R; Van Poppel H
Prostate Cancer Prostatic Dis; 2003; 6(4):305-10. PubMed ID: 14663472
[TBL] [Abstract][Full Text] [Related]
12. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer.
Schoenfield L; Jones JS; Zippe CD; Reuther AM; Klein E; Zhou M; Magi-Galluzzi C
BJU Int; 2007 Apr; 99(4):770-4. PubMed ID: 17233800
[TBL] [Abstract][Full Text] [Related]
13. Multifocal high grade prostatic intraepithelial neoplasia is a risk factor for subsequent prostate cancer.
Lee MC; Moussa AS; Yu C; Kattan MW; Magi-Galluzzi C; Jones JS
J Urol; 2010 Nov; 184(5):1958-62. PubMed ID: 20846692
[TBL] [Abstract][Full Text] [Related]
14. Widespread high-grade prostatic intraepithelial neoplasia on prostatic needle biopsy: a significant likelihood of subsequently diagnosed adenocarcinoma.
Netto GJ; Epstein JI
Am J Surg Pathol; 2006 Sep; 30(9):1184-8. PubMed ID: 16931964
[TBL] [Abstract][Full Text] [Related]
15. ERG overexpression and multifocality predict prostate cancer in subsequent biopsy for patients with high-grade prostatic intraepithelial neoplasia.
Shah RB; Li J; Dhanani N; Mendrinos S
Urol Oncol; 2016 Mar; 34(3):120.e1-7. PubMed ID: 26585946
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis of isolated high-grade prostatic intra-epithelial neoplasia: proposal of a nomogram for the prediction of cancer detection at saturation re-biopsy.
Roscigno M; Scattoni V; Freschi M; Abdollah F; Maccagnano C; Galosi A; Lacetera V; Montironi R; Muzzonigro G; Deho F; Deiana G; Belussi D; Chinaglia D; Montorsi F; Da Pozzo LF
BJU Int; 2012 May; 109(9):1329-34. PubMed ID: 21895935
[TBL] [Abstract][Full Text] [Related]
17. Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.
Raghow S; Hooshdaran MZ; Katiyar S; Steiner MS
Cancer Res; 2002 Mar; 62(5):1370-6. PubMed ID: 11888907
[TBL] [Abstract][Full Text] [Related]
18. The presence of high-grade prostatic intraepithelial neoplasia or atypia on prostate biopsy does not adversely affect prostatectomy outcomes for patients otherwise eligible for active surveillance.
Pietzak EJ; Kabarriti AE; Mucksavage P; Bavaria T; Van Arsdalen K; Malkowicz SB; Wein AJ; Guzzo TJ
Urology; 2014 Dec; 84(6):1442-7. PubMed ID: 25288572
[TBL] [Abstract][Full Text] [Related]
19. Chronic inflammation is negatively associated with prostate cancer and high-grade prostatic intraepithelial neoplasia on needle biopsy.
Karakiewicz PI; Benayoun S; Bégin LR; Duclos A; Valiquette L; McCormack M; Bénard F; Saad F; Perrotte P
Int J Clin Pract; 2007 Mar; 61(3):425-30. PubMed ID: 17313610
[TBL] [Abstract][Full Text] [Related]
20. The proportion of cores with high-grade prostatic intraepithelial neoplasia on extended-pattern needle biopsy is significantly associated with prostate cancer on site-directed repeat biopsy.
Akhavan A; Keith JD; Bastacky SI; Cai C; Wang Y; Nelson JB
BJU Int; 2007 Apr; 99(4):765-9. PubMed ID: 17378840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
